TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CHRS

Coherus BioSciences Inc

Healthcare · Biotechnology

1.20$ -7.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Coherus BioSciences Inc (CHRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 191 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CHRS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
192 178 227 172 190 163 128 188 141 99 186 240 327 409 467 757 804 842 693 740 742 679 593 546 551 481 402 470 584 630 764 675 505 449 371 439 517 258 266 191
177 125 208 153 172 127 112 173 130 72 159 212 298 343 395 676 727 767 617 660 673 602 512 447 448 381 316 385 444 476 627 558 369 342 310 380 461 207 206 134
160 125 125 73 136 127 82 130 101 72 82 106 165 178 193 225 292 541 259 330 361 417 326 275 287 64 17 73 81 103 260 159 98 126 82 217 103 89 115 83
160 125 175 118 150 127 95 160 117 72 96 112 170 178 193 456 503 541 400 454 469 417 326 275 287 192 129 145 132 118 260 159 98 126 82 238 192 172 167 105
0.4 1.9 0.0 – – – – – – -1.7 46 77 90 142 167 172 161 157 140 142 136 123 117 116 91 110 101 141 217 261 284 314 199 122 62 120 250 18 23 14
17 -4.8 31 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.3 23 38 9.8 16 27 35 44 52 40 38 38 37 32 28 39 49 64 67 63 62 62 48 70 3.5 4.5 2.0 3.2 4.8 5.7
11 11 15 15 14 13 12 11 6.8 11 13 12 17 16 18 21 51 48 52 18 46 63 67 86 87 85 73 71 – – – – – – – – – – – –
0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 – – – 0.9 – – 0.9 0.9 0.0 0.0 0.0 0.0 – – – – – –
2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 3.6 3.6 6.0 5.0 5.9 5.8 46 71 57 55 54 54 53 52 49 46 46 45
161 159 151 141 135 132 132 126 129 138 225 244 271 304 309 543 548 561 566 583 611 582 581 569 648 618 599 644 717 823 845 759 593 581 555 320 429 197 187 130
58 56 47 36 31 28 28 22 25 33 41 61 94 115 119 130 133 146 258 287 320 165 154 141 171 139 123 169 240 332 538 463 296 283 255 265 374 142 132 76
2.9 0.9 2.1 18 101 0.2 0.2 102 – – 2.1 2.2 2.0 2.2 – 2.9 11 3.1 110 122 129 3.5 3.4 4.0 4.1 4.3 4.4 4.4 4.5 2.1 177 4.1 1.6 1.7 1.7 1.8 1.8 1.8 1.9 –
23 21 15 16 10 16 14 13 7.6 15 11 19 14 26 20 21 12 15 15 15 46 16 21 17 9.9 12 23 29 37 35 38 77 22 28 41 38 25 9.9 11 13
75 75 75 76 76 76 76 77 77 77 177 177 178 178 179 402 377 377 298 287 282 408 225 225 225 226 226 226 473 473 300 264 265 265 265 37 37 37 37 37
33 19 78 32 56 31 -1.8 63 12 -39 -39 -4.0 56 105 157 213 256 281 128 156 131 98 13 -23 -97 -137 -197 -175 -134 -193 -82 -84 -88 -132 -183 120 88 61 79 61
-461 -537 -612 -667 -726 -775 -820 -863 -922 -985 -1,005 -981 -934 -895 -859 -800 -772 -763 -936 -966 -1,004 -1,050 -1,146 -1,196 -1,283 -1,342 -1,417 -1,460 -1,500 -1,580 -1,477 -1,490 -1,500 -1,551 -1,608 -1,310 -1,345 -1,383 -1,421 -1,442
52 44 49 51 54 58 60 64 68 68 69 73 79 78 74 89 87 88 73 76 79 77 77 78 78 78 79 87 98 111 126 115 115 115 116 116 116 120 136 155

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?